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Abstract 
This study examined the relationship among health expenditure, health outcomes and economic 
growth in Nigeria for the period between 1981 and 2017. This study adopted the Toda-
Yamamoto causality framework to examine these relationships. The Augmented Dickey Fuller 
unit root test was used to check for maximum order of integration of the variables used in the 
study and the result was one while the Autoregressive Distributed Lag (ARDL) Bounds test 
approach to cointegration was used to investigate if a long-run relationship exists among the 
macroeconomic variables used in the study and the result was in the affirmative. The results of the 
Toda-Yamamoto causality tests showed a unidirectional causality running from health 
expenditure to infant mortality while there is no causality between real GDP and infant mortality; 
a unidirectional causal relationship running from health expenditure and real GDP to life 
expectancy and maternal mortality; and a unidirectional causal relationship running from real 
GDP to health expenditure. This study therefore recommended that the Nigerian government 
should make concerted efforts geared towards increasing the health expenditure at least to meet 
up with the WHO‟s recommendation that all countries should allocate at least 13 per cent of their 
annual budget to the health sector for effective funding as this would bring desired health 
outcomes and employ the use of modern technology and the services of professional health 
personnel should be sought to combat the high incidence of maternal and infant mortality in the 
health sector in Nigeria. 
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Contribution of this paper to the literature 
This paper contributes to the extant literature by examining the relationship among health 
expenditure, health outcomes and economic growth in Nigeria in a trivariate framework.  
 
1. Introduction 
The state of health of the population of a country is a major factor driving productivity as only a healthy labour 
force can make meaningful contributions to production and growth of national output. As is the case in a typical 
production function, the quantity / level of inputs has a corresponding effect on the quantity / level of output 
depending on the scale of production and returns to scale. Hence, this make the health of the citizens of a country 
imperative and as such adequate provision for health should be one of the primary goals of government as it has a 
positive impact on economic growth, one of the macroeconomic goals of every government.  
Similarly, the health of the population is influenced by both the type of health system and of their resources. 
The relationship between resources and outcomes helps one to effectively assess how functional the health system 
of a country is. A country has a health system with a better performance than another country, if, for the same level 
of resources, it generates better health outcomes, or if it generates the same outcomes but with fewer resources 
(Elola et al., 1995). Health systems are financed either through taxes, in the case of healthcare services owned by 
the state (national health services), or through income-related social contributions (social security systems) (Elola 
et al., 1995). The contribution of social security to the sustenance of the finance of the health system is phenomenal 
in countries with high income per capita. 
It is one of the major duties of every government to provide funds for the provision of social welfare of which 
health care is an integral part. Thus, government devotes public fund to the provision of health care services in a 
bid to improving the health of the citizenry so as to enable them make significant contributions to economic 
growth and development in the country. It is believed that an increase in budgetary allocation to social services 
should enhance service delivery but this is not the case in Nigeria. In many developing countries, budget 
misappropriation and/or mismanagement is one of the primary causes of ineffective public spending (World Bank, 
1998). For instance, many health indicators show that Nigeria ranks low in health status despite the increasing 
budgetary allocation to the health sector. UNAIDS, in 2016, ranked Nigeria as the second largest country with the 
prevalence of HIV/AIDS in the world. In 2017, Central Intelligence Agency (CIA) also ranked Nigeria as the 
eighth country with the highest infant mortality rate (69.8 per 1000 live birth) in the world. Furthermore, the 
United Nations Department of Economic and Social Affairs (UN DESA) says Nigeria‟s life expectancy stands at 
52.29 years, the 194th in the world.  
This statistics is indicative of the fact that the expenditure on health is not enough to develop the health system 
of Nigeria or appropriate policies are not put in place to improve the health system of the country. The cost of 
health is on the high side and in a bid to bridge the huge health funding gap by governments to its citizens, 
especially in developing and underdeveloped countries, the WHO recommended that countries should allocate at 
least 13 per cent of their annual budget to the health sector for effective funding. All member countries, including 
Nigeria signed towards the recommendation. Also, an Abuja Declaration, signed in 2001 by all member countries 
of the African Union, including Nigeria, who in fact was the host of the high powered meeting, recommended that 
for the continent to be at par with other nations of the world in terms of healthcare provision, 15 per cent of their 
annual budget, at the least, be allocated to the health sector. However, the budgetary allocation to the health sector 
(government health expenditure) has been below par over time implying that a large percentage of healthcare 
services will be funded from out-of-pocket which majority of Nigerians cannot afford.  
The Nigerian economy is highly import-dependent not only on goods but also on services to the extent that 
her political office holders as well as the rich import medical services either by employing the services of foreign 
medical experts to Nigeria or travelling abroad for medical check-up and/or treatment thereby enriching foreign 
nations at the expense of the domestic economy. For instance, the present president of Nigeria, Muhammadu 
Buhari, went on medical vacation in early 2017 for over 50 days after which he went for another medical vacation 
for a staggering 103 days in May, 2017. This attitude by the president, other politicians and the rich alike shows 
that they do not believe in the services rendered by resident medical practitioners as most of the equipment and 
machines used in Nigerian are outdated and cannot measure up to what obtains in developed countries of the 
world. Consequently, there is an increase in brain-drain as competent medical personnel migrate to developed 
countries of the world, where sophisticated medical equipment and machines are available, to enhance their 
productivity and keep up with the pace of development in the medicine. Consequently, this reduces the labour force 
in the health sector thereby reducing the sector‟s contribution to GDP and the aggregate national output at large. 
Several policies and institution frameworks have been instituted to improve the performance of the Nigerian 
health sector overtime. These policies include: National Population Policy of 1988, National Population Policy for 
Sustainable Development of 2004 and the National Population Policy of 2006. The institutional frameworks 
include: The National Population Commission (NPC), The National Planning Commission and the Federal 
Ministry of Health which comprises of four agencies whose activities directly or indirectly affect the demographic 
structure of Nigeria namely: the National Primary Health Care Development Agency (NPHCDA), the National 
Health Insurance Scheme (NHIS), the Nigerian Institute of Medical Research (NIMR) and the National Agency for 
Food and Drug Administration and Control (NAFDAC). However, these efforts of the government have not 
yielded the desired results given the maladies bedeviling the Nigerian health sector. 
The literature is replete with studies on the issues relating to public health expenditure and health outcomes in 
different countries of the world (Kim and Lane, 2013) (17 OECD Countries); (Novignon et al., 2012) (44 Sub-Sahara 
African Countries); Anyanwu and Erhijakpor (2007) (47 African Countries); (Elola et al., 1995) (17 Western 
European Countries); (Novignon and Lawanson, 2016) (45 Sub-Saharan African Countries); (Kulkarni, 2016)  
(BRICS Countries); (Deluna and Peralta, 2014) (Philippines), (Day and Tousignant, 2005)  (Canada); (Becchetti et 
al., 2015) (European countries); (Jaba et al., 2014) (175 World Countries); (Ogungbenle et al., 2013) (Nigeria); 
(Edeme et al., 2017) (Nigeria); among other]. While some studies Jaba et al. (2014); and Ogungbenle et al. (2013) 
focused on the impact of health expenditure on life expectancy, some focused on the relationship between public 
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health expenditure and mortality rate which are the only a small fraction of the overall health indicators/outcomes 
of an economy. Hence, the literature contains only a few studies on the empirical examination of the relationship 
between public health expenditure and health outcomes using only about two health indicator as a proxy for health 
outcome. This study will take a panoramic view of the health outcomes/indicators of an average household in the 
Nigerian economy by examining the relationship between public health expenditure and three major health 
outcomes (life expectancy, infant mortality, and maternal mortality) in Nigeria and also extend the analysis to 
investigating the impact of these health outcomes on the growth of the Nigerian economy. Another novelty of this 
study lies in the fact that it employs the use of the Toda-Yamamoto causality test to examine the relationship 
among health expenditure, health outcomes and economic growth, a technique that is particularly rare in the 
extant literature.  
It is against this background that this study will empirically investigate the relationship between health 
expenditure and health outcomes as well as the impact of health outcomes on economic growth in Nigeria for the 
period between 1981 and 2016. It also checks for the direction of causal relationship of these macroeconomic 
variables. The rest of this paper is structured in the following manner: Section 2 discusses the trend analysis of key 
variables; Section 3 comprises the review of related studies; Section 4 contains the methodology, model 
specification and empirical analysis; and Section 5 concludes the study. 
 
2. Health Expenditure, Health Outcomes and Real GDP Profile in Nigeria 
Figure 1 presents the profile of government expenditure on health and the corresponding health outcomes as 
well as the real GDP of Nigeria. A cursory look at Figure 1 reveals that government expenditure on health 
fluctuated for most the period under review even though there was a significant increase in it during the period. It 
grew steadily from N0.80 billion in 1981 to N0.62 billion in 1991, plummeted the following year to N0.15 billion 
and grew sharply to N3.87 billion in 1993 after which it fluctuated but stood at N16.64 billion in 1999. However, it 
is noteworthy that it grew markedly by about 134 percent from N99.1 billion in 2010 to N231.8 billion in 2011 
from when it plummeted and stood at N202.36 billion in 2016. On the other hand, the share of health expenditure 
in total government expenditure stabilized at 1.74 percent from 1981 to 1986 but fell sharply to 0.26 percent in 
1987 from when it rose to stand between 2.3 – 3.7 percent from 1993 – 2000. Moreover, it grew to 4 and 5 percent 
in 2001 and 2002 respectively. The highest share of health expenditure in total government expenditure was in 
2011 when it stood at 6.99 percent which falls short of the WHO recommendation as well as 2001 Abuja 
Declaration of the African Union that countries should allocate at least 13 per cent of their annual budget to the 
health sector for effective funding. This indicates that Nigeria falls below par in the expected expenditure on 
health. 
In addition, it is obvious that real GDP grew steadily almost throughout the period under review except for a 
few years (1982-1984 and 2016). The Nigerian economy plunged into economic crises during these periods and the 
Bretton Woods institutions, in a bid to salvage the Nigerian economy in the 1980s, introduced the Structural 
Adjustment Programmes (SAP) to Nigeria which later aggravated the economic crises it was meant to solve. Also, 
the Nigerian economy plunged into a recession in recently (2016) when her real GDP fell from N69023 billion in 
2015 to N67931 billion in 2016.  
Figure 1 also shows that infant mortality rate stood at 125.4 per 1,000 live births in 1981 but declined to 124 
per 1,000 live births in 1983 and increased steadily to 126.2 in 1989 and 1990. However, it plummeted in 126 per 
1,000 live births in 1991 from when it decreased steadily until it reached a double figure of 99.8 per 1,000 live 
births in 2004 and stood at 81.1 and 66.9 per 1,000 live births in 2010 and 2016 respectively. This downward trend 
could be linked to the advancement in medical science. In the same vein, maternal mortality rate stood at 362.41 
per 1,000 female adults in 1981 and it fluctuated from then till 1993 when it stood at 363.8 per 1,000 female adults. 
It however increased steadily to 393.53 per 1,000 female adults in 2002 but declined from then until it reached 
359.82 and 333.03 per 1,000 female adults in 2010 and 2016 respectively. This indicates that the effort of the 
Nigerian government in combating maternal mortality is yielding the desired fruit. 
Additionally, life expectancy at birth in Nigeria stood at 45.62 years in 1981 increased steadily to 46.13 in 
1985. It however declined to 45.84 years in 1993 and 1994 but increase in 1995 to 48.25 years and has since then 
maintained an upward trend till it reached 48.25 years, 50.85 years and 53.43 years in 2005, 2010 and 2016 
respectively. Figure 1 reveals that life expectancy at birth is relatively stable throughout the period under review. 
It is also apparent that infant mortality as well as maternal mortality rose for some time but declined gradually for 
most part of the period under review. On the other hand, real GDP maintained an upward trend almost throughout 
the period under review while government health expenditure had some spikes and also grew for most part of the 
period under review but fell in 2016 when Nigeria plunged into a recession. This suggests that the recession in 
Nigeria in 2016 reduced government expenditure on health. 
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Figure-1. Trends of health expenditure, health outcomes and real GDP in Nigeria. 
                  Source: CBNSB (2017) and WDI (2018). 
 
3. Literature Review 
There is a plethora of time-series and panel studies examining the nexus among health expenditure, health 
outcomes and economic growth. For instance, Dormont et al. (2007) adopted the Pooled OLS, fixed effect and 
random effect models to examine the relationships between health spending, medical innovation, health status, 
growth and welfare and found that health spending triggers technological progress, which is a potential source of 
better outcomes in terms of longevity and quality of life, a direct source of growth for the bio-tech industries and 
an indirect source of growth through improved of human capital. The latter contributes to GDP per capita through 
two main channels: higher participation of the population in the labour force and higher labour productivity levels. 
In turn, income growth induces an increase in health expenditure, as richer countries tend to spend a higher share 
of their income on health.  
Becchetti et al. (2015) investigated the impact of health expenditure on health outcomes on a large sample of 
Europeans aged above 50 using individual and regional-level data. The results showed that health expenditure to 
GDP and health expenditure per capita have a negative and significant impact on changes in the number of chronic 
diseases. It also showed that health expenditure produces heterogeneous effects on health outcomes, being more 
relevant for the elders, females, the overweight/obese, the below-median income group and for the less-educated 
vis-à-vis their complementary samples. After controlling for real per capita income, literacy level, and female 
participation in the labour market, Boachie and Ramu (2015) adopted the OLS and Newey-west estimation 
techniques and found evidence that the declining or falling infant mortality rate in Ghana has been influenced by 
public health spending among other factors.  
Kulkarni (2016) used the panel data regression with fixed effects model to examine the differences in the health 
care systems of Brazil, India, China, Russian Federation and South Africa, the emerging economies of BRICS. The 
results show a positive relation between health outcome and the GDP per capita, adult literacy rate, and out-of-
pocket expenditure; environmental pollution has a negative relation with health outcomes; and age dependency 
ratio and public health expenditure also show a positive elasticity with infant mortality rate. Kim and Lane (2013) 
analyzed the relationship between public health expenditure and national health outcomes among developed 
countries. The findings showed a negative relationship between government health expenditure and infant 
mortality rate, and a positive relationship between government health expenditure and life expectancy at birth. 
Jaba et al. (2014) analyzed the relationship between the dynamics of the inputs and the outputs of health care 
systems and found that there is a significant relationship between health expenditures and life expectancy and that 
country effects are significant and show the existence of important differences among the countries. 
In their study, Deluna and Peralta (2014) examined the relationship among public health expenditures, income 
and health outcomes in the Philippines. The results showed that infant mortality rate is inversely related to health 
expenditure per capita and GDP per capita. In their study on the dynamic analysis of the relationship among health 
spending, health outcomes and per capita income in Canada, Day and Tousignant (2005) employed the vector 
autoregression (VAR) model and the generalized impulse response function estimation technique and found 
evidence of a weak statistically significant relationship between per capita health spending, health outcomes, and 
per capita GDP. Gani (2009) examined the relationship between per capita public health expenditure and three 
measures of health outcomes for seven Pacific Island countries. The result provided strong evidence that per capita 
health expenditure is an important factor in determining health outcomes. The empirical results also provide 
strong evidence that per capita incomes and immunization are additional core factors that determine health 
outcomes.  
Novignon and Lawanson (2016) sought to understand the relationship between child health outcomes and 
health spending while investigating lagged effects. The results show a positive and significant relationship between 
health expenditure and child health outcomes. Public health expenditure was found to be relatively more significant 
than private expenditure. Novignon et al. (2012) employed the fixed and random effects panel data regression 
model estimation techniques to assess the effect of health care expenditure on population health status and to 
examine the effect by public and private expenditure sources. The results show that health care expenditure 
significantly influences health status through improving life expectancy at birth, reducing death and infant 
mortality rates. Both public and private health care spending showed strong positive association with health status 
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even though public health care spending had relatively higher impact. Edeme et al. (2017) investigated the effect of 
public health expenditure on health outcomes in Nigeria and found that an increase in public health expenditure 
improves life expectancy and reduces infant mortality rates. 
Anyanwu and Erhijakpor (2007) employed the Robust Ordinary Least Squares (ROLS) model and Robust 
Two-Stage Least Squares (R2SLS) techniques to provide econometric evidence linking African countries‟ per capita 
total as well as government health expenditures and per capita income to infant mortality and under-five mortality. 
Health expenditures have a statistically significant effect on infant mortality and under-five mortality. In addition, 
both infant and under-five mortality are positively and significantly associated with Sub-Saharan Africa while the 
reverse is true for North Africa. Piabuo and Tieguhong (2017) conducted a comparative analysis on the impact of 
health expenditure between countries in the CEMAC sub-region and five other African countries that achieved the 
Abuja declaration. The results showed that health expenditure has a positive and significant effect on economic 
growth in both samples. In addition, a long-run relationship also exists between health expenditure and economic 
growth for both groups of countries. 
Matthew et al. (2015)  adopted the vector error correction model to examine government spending on health 
and its effect on health outcomes in Nigeria and found that public spending on health has a significant relationship 
with health outcomes in Nigeria and that environmental factors such as carbon dioxide emissions affects 
individuals‟ health. Similarly, Nwanosike et al. (2015) employed the ordinary least square estimation technique to 
investigate the progressive implication of malaria incidence and malaria spending on Nigeria health outcomes and 
found that increase in health expenditure and educational expenditure reduce malaria incidence. Yaqub et al. (2012) 
used the Ordinary Least Squares and the Two-Stage Least Squares estimation techniques to investigate how the 
effectiveness of public health expenditure is affected by governance in Nigeria and found that public health 
expenditure has negative effect on infant mortality and under-5 mortalities when the governance indicators are 
included. Maduka et al. (2006) examined the relationship among government health expenditure, health outcomes 
and economic growth in Nigeria using the using Toda and Yamamoto causality approach. The results revealed that 
government health expenditures indirectly influence economic growth through health outcomes such as mortality 
rate and life expectancy. 
In their empirical analysis of the relationship existing among life expectancy, public health spending and 
economic growth in Nigeria, Ogungbenle et al. (2013) found that there is no bi-directional causality between life 
expectancy and public health spending in Nigeria neither is a bi-directional causality between life expectancy and 
economic growth in Nigeria over the years. However, the study confirmed that there is bi-directional causality 
between public health spending and economic growth in Nigeria. Hooda (2014) examined the impact of different 
decentralized governance measures on infant and child mortality rates of rural India across states and in improving 
the efficacy of rural health spending. The result showed that states with high fiscal and political decentralisation 
have more significant impact in reducing the infant mortality compared to states having high fiscal but low 
political decentralisation, indicating efficacy of fiscal decentralisation increases with political decentralisation. 
 
4. Methodology, Model Specification and Empirical Analysis 
4.1. Methodology and Model Specification  
This study assesses the relationship among health expenditure, health outcomes and economic growth in 
Nigeria for the period between 1981 and 2016 using the Toda-Yamamoto causality test. The aim is to examine how 
health expenditure influences health outcome and economic growth; how health outcomes influence health outcome 
and economic growth; and how economic growth influences health expenditure and health outcome. Whereas 
government expenditure on health is used as a proxy for health expenditure, real GDP growth is used as proxy for 
economic growth and the variables of health outcomes for this study include: life expectancy, infant mortality and 
maternal mortality. Data for the period between 1981 and 2017 on infant mortality, life expectancy and maternal 
mortality are sourced from World Development Indicators (2018) while data on health expenditure and real GDP 
are sourced from Central Bank of Nigeria Statistical Bulletin (2017) Following Wolde-Rufael (2005) and Maduka et 
al. (2016) this study employs the Granger non-causality test, a Toda–Yamamoto procedure that is applicable 
regardless of whether a series is I(0), I(1), or I(2), non-cointegrated or cointegrated of any order. This implies that 
it avoids the potential bias associated with unit root and cointegration tests. As pointed out by Clarke and Mirza 
(2006) pre-tests for unit root and cointegration might suffer from size distortion, which often implies the use of an 
inaccurate model for the non-causality test. To obviate some of these problems, the Toda-Yamamoto test, based on 
augmented VAR modeling, introduced a Wald test statistic that asymptotically has a chi-square distribution 
irrespective of the order of integration or cointegration properties of the variables. The Toda–Yamamoto approach 
ﬁts a standard vector autoregression and a vector error correction model on levels of the variables (not on their 
ﬁrst differences) and therefore makes allowances for the long-run information often ignored in systems that require 
ﬁrst differencing and pre-whitening (Clarke and Mirza, 2006). The approach employs a modiﬁed Wald test 
(MWALD) for restrictions on the parameters of the VAR (k), where k is the lag length of the system. The basic 
idea of the Toda-Yamamoto approach is to artiﬁcially augment the correct order, k, by the maximal order of 
integration, say dmax. Once this is done, a (k + dmax) the order of VAR is estimated and the coefﬁcients of the last 
lagged dmax vectors are ignored. 
Based on the foregoing and following the specification of Maduka et al. (2016) the relationship between health 
expenditure, health outcomes and economic growth are represented mathematically as follows: 
LEXP = f (HEXP, RGDP)                                                                              (1) 
IFM = f (HEXP, RGDP)                                                                              (2) 
MMT = f (HEXP, RGDP)                                                                                  (3) 
RDGP = f (HEXP, LEXP, IFM, MMT, FTR)                                                    (4) 
HEXP = f (RGDP, LEXP, IFM, MMT, FTR)                                              (5) 
The econometric representations of the above mathematical equations are as follow:  
LEXP = α0 + α1HEXP + α2RGDP + 𝜺1                                                           (6) 
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IFM = β0 + β1HEXP + β2RGDP + 𝜺2                                                      (7) 
MMT = δ0 + δ1HEXP + δ2RGDP) + 𝜺3                                                           (8) 
RDGP = ϑ0 + ϑ1HEXP + ϑ2LEXP + ϑ3IFM + ϑ4MMT + ϑ5FTR + 𝜺5              (9) 
HEXP = σ0 + σ1RGDP + σ2LEXP + σ3IFM + σ4MMT + σ5FTR + 𝜺6               (10) 
The Toda and Yamamoto (1995) version of the above specified models representing the nexus among health 
expenditure, health outcomes and economic growth are in the following VAR system: 
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Where: 
LEXP = Life expectancy. 
IFM = Infant mortality. 
MMT = Maternal mortality rate. 
HEXP = Health expenditure. 
RGDP = Real gross domestic product (Proxy for economic growth). 
α, β, δ, θ, ϑ and σ = Coefficients of the independent variables. 
γit = White noise stochastic error term. 
 
4.2. Empirical Analysis 
4.2.1. Preliminary Analysis 
4.2.1.1. Descriptive Statistics 
Table 1 presents the descriptive characteristics of the macroeconomic variables used in this study. The average 
value of health expenditure, infant mortality, life expectancy, maternal mortality rate and real GDP are N58.85 
billion, 105.78 per 1000 live births, 47.91 years, 364.95 per 1000 female adults and N32749.95 billion respectively. 
This suggests that maternal mortality rate is still very high in Nigeria and infant mortality is as well relatively 
high indicating that more women than children die in the course of child birth. This suggests that there is a dire 
need to upgrade the child delivery facilities in the country to lower the incidence of maternal and infant mortality. 
The mean values of health expenditure and real GDP also show that the percentage of government expenditure on 
health is extremely low and this could be the reason for the high maternal and infant mortality rate in Nigeria. 
Furthermore, the probability values of the Jarque-Bera statistic of each variable show that the all the variables 
are normally distributed given the probability value of the Jarque-Bera statistic. In addition, for a series to be said 
to be normally distributed, the value of skewness should be zero or not be statistically different from zero. 
Accordingly, all the variables except health expenditure meet this condition thus giving further credence to the 
assertion of normal distribution. Further, all the variables employed in this study are platykurtic except health 
expenditure which is leptokurtic given its kurtosis value. The result also shows that all the variables have a very 
high standard deviation signifying a high deviation from their respective mean values. 
 
Table-1. Descriptive statistics. 
 Statistics HEXP IFM LEXP MMT RGDP 
 Mean 58.85 105.78 47.91 364.95 32749.95 
 Median 15.22 115.20 46.13 360.32 22449.41 
 Maximum 257.72 126.20 53.72 393.74 69023.93 
 Minimum 0.04 65.50 45.64 331.45 13779.26 
 Std. dev. 82.51 21.58 2.67 15.54 18889.20 
 Skewness 1.26 0.61 0.97 0.14 0.80 
 Kurtosis 3.10 1.81 2.40 2.68 2.14 
 Jarque-Bera 9.79 4.46 6.37 0.27 5.10 
 Probability 0.1075 0.1074 0.1414 0.8749 0.1781 
 Sum 2177.54 3913.70 1772.74 13502.97 1211748.00 
Observations 37 37 37 37 37 
Where HEXP = Health expenditure; IFM = Infant mortality; LEXP = Life expectancy; MMT = Maternal 
mortality rate; and RGDP = Real gross domestic product. 
                                      
 
(11) 
(12) 
(13) 
(14) 
(15) 
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4.2.1.2. Unit Root Test 
Routinely, the time-series properties of macroeconomic variables need to be ascertained when carrying out 
time-series analysis so as to guard against obtaining spurious results. The appropriate test for checking these time-
series properties is unit root test. It tests the null hypothesis of the presence of unit root as against the alternative 
hypothesis of the absence of unit root. The decision rule is that the null hypothesis will be rejected and be 
alternative hypothesis accepted should the computed t-statistic be greater than the test critical values in absolute 
terms or the probability value be less than 0.1; it will be accepted and be alternative hypothesis rejected should the 
computed t-statistic be less than the test critical values in absolute terms or its probability value be greater than 0.1 
or 10 per cent significance level. 
This study employs the Augmented Dickey-Fuller (ADF) unit root test method to check the order of 
integration of the macroeconomic variables of this study and the results are presented in Table 2. The results show 
that infant mortality and life expectancy are stationary at level [I(0)] while health expenditure, maternal mortality 
rate and real GDP are stationary at first difference [I(1)]. This result shows that the macroeconomic variables 
employed in this study are a combination of I(0) and I(1) series or are integrated of different orders. This condition 
makes the ARDL Bounds test approach to cointegration appropriate for investigating the long-run relationship 
among these variable.  
 
Table-2. Unit root test results. 
 Augmented Dickey Fuller (ADF) 
Variables Level First difference I(d) 
HEXP -1.27c -2.94a** I(1) 
IFM -4.58*b - I(0) 
LEXP -3.67*b - I(0) 
MMT -0.96a -3.78b* I(1) 
RGDP -1.86b -5.45b* I(1) 
Note: *, ** and ***  represent statistical significance at 1%, 5% and 10% level respectively; „a‟ denotes 
model with constant and „b‟ is for model with trend and constant and trend. I(0) and I(1) indicate 
stationarity at level and first difference respectively. 
 
4.2.1.3. ARDL Bounds Test Approach to Cointegration 
In line with the result of the unit root test, cointegration test will be carried out using ARDL Bounds Test 
approach to cointegration. The choice of this approach is premised on the fact that our variables are integrated of 
different orders [(I(0) and I(1)], thus negating the use of Engle-granger and Johansen Cointegration test approach. 
Pesaran and Shin (1999) and Pesaran et al. (2001) developed the ARDL cointegration approach which has three 
major advantages over other traditional cointegration approaches. Firstly, the ARDL framework does not require 
that all the variables under study be of the same order of integration; it accommodates series which are I(0) or I(1) 
or both. Secondly, it is relatively more efficient using small sample sizes. Thirdly, the ARDL framework obtains 
unbiased estimates of the long-run model.  
The rule of ARDL Bounds test of cointegration states that the null hypothesis should be rejected if the value 
of the computed F-statistic is greater than the upper bounds value and accepted if the F-statistic is less than the 
lower bounds value. The ARDL cointegration test will be said to be inconclusive should the computed F-statistic 
fall within the lower and upper bound. Accordingly, Table 3 shows that the computed F-statistic (4.54) falls above 
the upper bound critical value at 5 and 10 percent level of significance. This implies that there is a long-run 
relationship among health expenditure, infant mortality, life expectancy, maternal mortality rate and real GDP. 
 
Table-3. ARDL bounds test result. 
Significance level 
Critical value 
Computed F-statistics 
Lower (I0) bound Upper (I0) bound 
1% 3.74 5.06 
 
5% 2.86 4.01 4.54 
10% 2.45 3.52  
The bounds critical values for k=5are obtained from Narayan (2005) case III for 40 observations. 
 
4.2.2. Result of Toda-Yamamoto Granger Causality Test 
This study employs the Toda-Yamamoto Granger Causality approach examine the direction of causal 
relationship among health expenditure, health outcomes and economic growth in Nigeria. Before carrying out the 
Toda-Yamamoto granger causality test, it is needful to estimate the highest order of integration (dmax) in the 
system which is derived from the result of the unit root test. A cursory look at the unit root test result in Table 2 
reveals that the maximum order of integration is one which implies that there will be an additional one lag to the 
VAR models. The next step after ascertaining the maximum order of integration is to determine the optimal lag 
length of the VAR model which is determined using the following criterions: sequential modified LR test statistic 
(LR), Final Prediction Error (FPE), Akaike Information Criterion (AIC), Schwarz Information Criterion (SC) as 
well as the Hannan Quinn (HQ) Information Criterion. Accordingly, the result of the VAR optimal lag length 
selection criteria is presented in Table 4. It is obvious that the various information criteria unanimously suggested 
the selection of a maximum lag length of 3 for each variable thus, the VAR model with lag length 3 will be 
estimated.  
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Table-4. VAR lag length selection criteria. 
Endogenous variables: HEXP IFM LEXP MMT RDGP 
Lag LogL LR FPE AIC SC HQ 
0 106.1440 NA 1.01e-09 -6.525417 -6.294128 -6.450023 
1 389.6865 457.3267 5.89e-17 -23.20558 -21.81785 -22.75322 
2 451.8915 80.26451 6.13e-18 -25.60590 -23.06173 -24.77657 
3 504.8231 51.22415* 1.49e-18* -27.40794* -23.70733* -26.20164* 
4 585.4645 52.02672 1.03e-19 -30.99771 -26.14066 -29.41443 
Where * indicates lag order selected by the criterion, LR = sequential modified LR test statistic (each test at 5% level), FPE = Final 
prediction error, AIC = Akaike information criterion, SC = Schwarz information criterion and HQ = Hannan-Quinn information criterion. 
 
The results of Toda-Yamamoto causality estimated by the modified Wald test are presented in Table 5. The 
results show that the test follows the chi-square distribution with 3 degrees of freedom which is in accordance with 
optimal lag length. The results of the Toda-Yamamoto causality test reveal that the null hypothesis that health 
expenditure does not granger causes infant mortality is rejected thus, health expenditure granger causes infant 
mortality in Nigeria while infant mortality does not granger cause health expenditure suggesting that there is a 
unidirectional causal relationship running from health expenditure to infant mortality. This result is plausible and 
in line with a priori expectation. It suggests that the health expenditure in Nigeria has been able to achieve a 
desired result (reduction in infant mortality) and that the effort of government and other stakeholder in the heath 
sector have not been in vain. This result is also consistent with findings by Novignon et al. (2012); Kulkarni (2016); 
Edeme et al. (2017). Also, real GDP does not granger cause infant mortality neither does infant mortality granger 
cause real GDP indicating that there is no causality between real GDP and infant mortality in Nigeria.  
Moreover, the result shows that health expenditure granger causes life expectancy while life expectancy does 
not granger cause health expenditure indicating that there is a unidirectional causality running from health 
expenditure to life expectancy. This suggests that health expenditure by the government has been able to improve 
the life expectancy at birth in Nigeria and that government‟s effort at improving the health sector of the Nigerian 
economy is yielding the desired result. This result in line with a priori expectation and parallels the findings of 
Maduka et al. (2006); Kim and Lane (2013); Jaba et al. (2014) but negates the findings of Ogungbenle et al. (2013). 
Similarly, real GDP granger causes life expectancy while life expectancy does not granger cause real GDP thus, 
indicating that there is a unidirectional causal relationship running from real GDP to life expectancy. This result is 
against the findings of Ogungbenle et al. (2013) who found a bidirectional causality running from real GDP to life 
expectancy and vice versa.  
Besides, there is a unidirectional causal relationship between health expenditure and maternal mortality rate in 
Nigeria as causality runs from health expenditure to maternal mortality rate but not the other way round. This 
result implies that health expenditure in Nigeria has been able to weakly combat maternal mortality given the 
probability value that is very close to 10 percent. Similarly, whereas real GDP granger causes maternal mortality, 
maternal mortality does not granger cause real GDP in Nigeria thus, suggesting a unidirectional causality running 
from real GDP to maternal mortality. This result is plausible and in line with a priori expectations as it implies 
that as the economy grows, maternal mortality rate reduces. This is the case in most developed economies and it 
can be attributed to the improvement in technology that has led to the invention of modern machines with which to 
preserve lives. 
More so, health expenditure does not granger cause real GDP but real GDP granger causes health expenditure 
in Nigeria suggesting that a there is a unidirectional causality running from real GDP to health expenditure in 
Nigeria. This suggests that economic growth is capable of increasing health expenditure or economic growth is 
capable of influencing the amount the government will spend on the health sector in Nigeria. This result is 
plausible and is in line with theoretical expectation. 
Summarily, health expenditure has a significant causal relationship with infant mortality, maternal mortality 
and life expectancy in Nigeria. In the same vein, real GDP has a significant causal relationship with maternal 
mortality and life expectancy in Nigeria. These results indicate that health expenditure has a significant causal 
relationship with health outcomes in Nigeria and the direction of relationship is unidirectional such that causality 
runs from health expenditure and health outcomes. This implies that the little efforts of the government in funding 
the health sector of the Nigerian economy are gradually yielding the desired fruit. On the other hand, real GDP 
causes/influences health outcomes in Nigeria and not the other way round. A unidirectional causality runs from 
real GDP to health outcomes in Nigeria. Finally, the result shows that it is real GDP that granger causes health 
expenditure and not the other way round. 
 
Table-5. Toda-Yamamoto causality (Modified wald) test results. 
Null hypotheses Chi-sq Df Prob. Direction of causality 
HEXP does not granger cause IFM 1.59 3 0.0136 Unidirectional 
HEXP  IFM IFM does not granger cause HEXP 0.81 3 0.8145 
RGDP does not granger cause IFM 1.27 3 0.7358 No causality 
IFM does not granger cause RGDP 2.29 3 0.5147  
HEXP does not granger cause LEXP 7.53 3 0.0568 Unidirectional 
HEXP  LEXP LEXP does not granger cause HEXP 3.39 3 0.3353 
RGDP does not granger cause LEXP 20.16 3 0.0002 Unidirectional 
RGDP  LEXP LEXP does not granger cause RGDP 1.06 3 0.7860 
HEXP does not granger cause MMT 13.62 3 0.0035 Unidirectional 
HEXP  MMT MMT does not granger cause HEXP 0.67 3 0.8797 
RGDP does not granger cause MMT 5.03 3 0.0142 Unidirectional 
RDGP  MMT MMT does not granger cause RGDP 0.10 3 0.9918 
HEXP does not granger cause RGDP 2.40 3 0.4944 Unidirectional 
RDGP  HEXP RGDP does not granger cause HEXP 11.49 3 0.0093 
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4.2.3. Diagnostic / Post-Estimation Test 
Before this result can be appropriate for policy formulation and/or prescription, it is needful to verify that the 
estimates of the chosen multivariate model are reliable. This will require diagnostic checks / post-estimation tests. 
The most relevant post-estimation test for multivariate models is the serial correlation test (using the LM test). It 
is carried out to test the presence of serial correlation in the estimated model thus, the null hypothesis of the serial 
correlation test is: “No Serial Correlation at Lag Order h.” The null hypothesis will be accepted if the probability 
value is greater than 10 percent and rejected of the probability value is less than 10 percent. Accordingly, Table 6 
presents the result of the Serial Correlation LM test and it shows that the probability values of the LM-Stat for 
each lag is greater than 10 percent thus, the null hypothesis of no serial correlation will be accepted indicating that 
the estimates of the model and its results are reliable for policy prescription.  
 
Table-6. Diagnostic test. 
VAR residual serial correlation LM tests 
Null hypothesis: No serial correlation at lag order h 
Lags LM-stat Prob. 
1 30.88705 0.2236 
2 25.91344 0.4122 
3 32.48781 0.1444 
4 19.47508 0.7738 
5 15.79846 0.8241 
 
5. Conclusion and Policy Implications 
The relationship between health expenditure, health outcomes and economic growth remains inconclusive in 
the extant literature hence, it is needful to ascertain these relationships so as to make evidence-based decision that 
would ameliorate the situation of the health sector of Nigeria. Given the high rate of infant and maternal mortality, 
the low life expectancy in Nigeria as well as the meagre budgetary allocation to the health sector of the Nigerian 
economy, it became imperative to examine the link between health expenditure, health outcomes and economic 
growth to actually see there is a causal relationship among these key macroeconomic variables in Nigeria.  
Hence, this study was carried out to examine the causal relationship as well as the direction of causality among 
health expenditure, health outcomes (infant mortality, life expectancy and maternal mortality) and economic 
growth in Nigeria using the ARDL Bounds test approach to cointegration and the Toda and Yamamoto (1995) 
causality test. Sequel to the empirical findings of this study, this study concludes that health expenditure and 
economic growth play key roles in determining the health outcomes in Nigeria. Specifically, causality runs from 
health expenditure to infant mortality, maternal mortality and life expectancy while causality runs from economic 
growth to life expectancy and maternal mortality. On the other hand, this study concludes that a unidirectional 
causal relationship exists between economic growth and health outcomes in Nigeria indicating that causality runs 
from economic growth to health expenditure. 
The implications of these findings for the Nigerian economy are hereby discussed. First, the non-causality 
between economic growth and infant mortality suggests that economic growth and infant mortality does not cause 
nor affect each other thus, that the government and the stakeholders in the health sector should endeavour to adopt 
technologies that would lower the incidence of infant mortality in Nigeria. Lastly, the unidirectional causality 
between health expenditure and economic growth as against the bidirectional causality found by Ogungbenle et al. 
(2013) suggests that the government need to formulate and implement policies that will stimulate economic 
growth which will in turn influence health expenditure, thereby instigating the desired health outcomes. Second, 
the unidirectional causality running from economic growth to health expenditure suggests that health expenditure 
does not cause economic growth thus, downplaying the contribution of the health sector of the Nigerian economy 
to aggregate output. This implies that while government spends on health sector, it should focus on the impact of 
health expenditure on health outcomes rather than economic growth. It also suggests that health expenditure does 
not have a direct but indirect effect on economic growth as it goes through health outcomes to influence economic 
growth. 
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